Outcome variable
|
Follow-up sessions
|
Coefficeint (rESWTa VS LCsIb)
|
p value
|
95% CI
|
---|
ᅟ
|
---|
Visual analogue scale
|
Baseline to week 1
|
−0.10
|
0.90
|
−1.7 to 1.5
|
Week 1 to week 4
|
0 .049
|
0.95
|
− 1.6 to 1.7
|
Week 4 to week 12
|
−1.0
|
0.23
|
−2.7 to 0.63
|
Week 12 to week 24
|
−1.2
|
0.17
|
− 2.9 to 0.49
|
Symptom severity score
|
Baseline to week 1
|
2.6
|
0.27
|
−2.0 to 7.2
|
Week 1 to week 4
|
1.5
|
0.53
|
−3.2 to 6.1
|
Week 4 to week 12
|
−1.9
|
0.43
|
−6.5 to 2.8
|
Week 12 to week 24
|
−5.1
|
0.036*
|
−9.8 to −0.33
|
Functional score
|
Baseline to week 1
|
0.43
|
0.81
|
−3.1 to 3.9
|
Week 1 to week 4
|
−0.20
|
0.91
|
−3.7 to 3.3
|
Week 4 to week 12
|
−1.8
|
0.32
|
−5.3 to 1.7
|
Week 12 to week 24
|
−4.5
|
0.015*
|
−8.1 to −0.87
|
Boston questionnaire score
|
Baseline to week 1
|
3.0
|
0.43
|
−4.5 to 11
|
Week 1 to week 4
|
1.3
|
0.74
|
−6.2 to 8.8
|
Week 4 to week 12
|
−3.7
|
0.34
|
−11 to 3.8
|
Week 12 to week 24
|
−9.5
|
0.015*
|
−17 to − 1.9
|
Peak sensory distal latency
|
Baseline to week 12
|
−0.24
|
0.022*
|
− 0.44 to − 0.034
|
SNAPc amplitude
|
Baseline to week 12
|
−2.8
|
0.36
|
−8.9 to 3.2
|
Motor distal latency
|
Baseline to week 12
|
−0.038
|
0.84
|
−0.41 to 0.33
|
CMAPd amplitude
|
Baseline to week 12
|
−0.44
|
0.34
|
−1.4 to 0.46
|
- *p < 0.05
- arESWT = Radial extracorporeal shockwave therapy
- bLCsI = Local corticosteroid injection
- cSNAP = Sensory nerve action potential
- dCMAP = Compound muscle action potential